• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

预防动脉粥样硬化性心脑血管疾病：东亚地区冠心病血压管理的关键目标。

Prevention of atherosclerotic cerebro-cardiovascular disease: a key objective in blood pressure management for coronary artery disease in East Asia.

作者信息

Kai Hisashi

机构信息

Department of Cardiology, Kurume University Medical Center, Kurume, Fukuoka, 839-0863, Japan.

出版信息

Hypertens Res. 2025 Feb;48(2):830-832. doi: 10.1038/s41440-024-01966-3. Epub 2024 Oct 30.

DOI:10.1038/s41440-024-01966-3
PMID:39478192
Abstract

Atherosclerotic cerebro-cardiovascular disease is multi-vascular and multi-organ disease resulting from both chronic and acute risk factors. BP, blood pressure; ACS, acute coronary syndrome, CCS, chronic coronary syndrome; HFrEF, heart failure with reduced ejection fraction; HFpEF heart failure with preserved ejection fraction, PAD peripheral artery disease, CKD chronic kidney disease, RF renal failure.

摘要

动脉粥样硬化性心脑血管疾病是一种由慢性和急性危险因素导致的多血管、多器官疾病。BP，血压；ACS，急性冠状动脉综合征；CCS，慢性冠状动脉综合征；HFrEF，射血分数降低的心力衰竭；HFpEF，射血分数保留的心力衰竭；PAD，外周动脉疾病；CKD，慢性肾脏病；RF，肾衰竭。

相似文献

1
Prevention of atherosclerotic cerebro-cardiovascular disease: a key objective in blood pressure management for coronary artery disease in East Asia.预防动脉粥样硬化性心脑血管疾病：东亚地区冠心病血压管理的关键目标。
Hypertens Res. 2025 Feb;48(2):830-832. doi: 10.1038/s41440-024-01966-3. Epub 2024 Oct 30.
2
Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction.中重度射血分数降低的急性心力衰竭患者血压升高模式的差异。
ESC Heart Fail. 2019 Oct;6(5):1057-1067. doi: 10.1002/ehf2.12500. Epub 2019 Jul 19.
3
[Pathological characteristics of the heart and coronary artery from elderly heart failure patients with preserved ejection fraction and coronary artery disease].老年射血分数保留的心力衰竭合并冠状动脉疾病患者心脏及冠状动脉的病理特征
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Aug 24;45(8):710-715. doi: 10.3760/cma.j.issn.0253-3758.2017.08.018.
4
Secondary prevention in concurrent coronary artery, cerebrovascular, and chronic kidney disease: focus on pharmacological therapy.合并冠状动脉、脑血管和慢性肾脏病时的二级预防：聚焦药物治疗
Cardiovasc Ther. 2009 Fall;27(3):199-215. doi: 10.1111/j.1755-5922.2009.00087.x.
5
[Clinical features and prognosis of patients with different types of heart failure in relation to coronary artery disease].[不同类型心力衰竭患者与冠状动脉疾病相关的临床特征及预后]
Zhonghua Yi Xue Za Zhi. 2020 Apr 21;100(15):1142-1147. doi: 10.3760/cma.j.cn112137-20190717-01585.
6
Extrarenal atherosclerotic disease blunts renal recovery in patients with renovascular hypertension.肾外动脉粥样硬化疾病会削弱肾血管性高血压患者的肾脏恢复能力。
J Hypertens. 2014 Jun;32(6):1300-6. doi: 10.1097/HJH.0000000000000160.
7
Achievement of guideline-recommended target blood pressure is associated with reducing the risk of hemorrhagic and ischemic stroke in Japanese coronary artery disease patients -the CLIDAS study.在日本冠状动脉疾病患者中，达到指南推荐的目标血压与降低出血性和缺血性中风风险相关——CLIDAS研究
Hypertens Res. 2025 Feb;48(2):632-639. doi: 10.1038/s41440-024-01902-5. Epub 2024 Sep 19.
8
Ankle-brachial index and incident heart failure with reduced versus preserved ejection fraction: The Multi-Ethnic Study of Atherosclerosis.踝臂指数与射血分数降低型和射血分数保留型心力衰竭的发病关系：动脉粥样硬化多民族研究。
Vasc Med. 2019 Dec;24(6):501-510. doi: 10.1177/1358863X19870602. Epub 2019 Sep 4.
9
Hitting the mark: blood pressure targets and agents in those with prevalent cardiovascular disease and heart failure.达标：患有心血管疾病和心力衰竭患者的血压目标及药物治疗
Adv Chronic Kidney Dis. 2015 Mar;22(2):140-4. doi: 10.1053/j.ackd.2014.10.005.
10
Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.CORAL试验中动脉粥样硬化性肾动脉狭窄支架置入术对估算肾小球滤过率的影响及临床事件的预测因素
Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1180-1188. doi: 10.2215/CJN.10491015. Epub 2016 May 25.

本文引用的文献

1
Systemic hemodynamic atherothrombotic syndrome (SHATS) - Coupling vascular disease and blood pressure variability: Proposed concept from pulse of Asia.系统性血流动力动脉粥样血栓综合征（SHATS）——血管疾病与血压变异性的耦合：来自亚洲脉搏的概念建议。
Prog Cardiovasc Dis. 2020 Jan-Feb;63(1):22-32. doi: 10.1016/j.pcad.2019.11.002. Epub 2019 Dec 4.
2
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).日本高血压学会高血压管理指南（JSH 2019）。
Hypertens Res. 2019 Sep;42(9):1235-1481. doi: 10.1038/s41440-019-0284-9.
3
Effects of lowering diastolic blood pressure to <80 mmHg on cardiovascular mortality and events in patients with coronary artery disease: a systematic review and meta-analysis.
降低舒张压至<80mmHg 对冠心病患者心血管死亡率和事件的影响：系统评价和荟萃分析。
Hypertens Res. 2019 May;42(5):650-659. doi: 10.1038/s41440-018-0189-z. Epub 2019 Apr 5.
4
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.降压预防心血管疾病和死亡：系统评价和荟萃分析。
Lancet. 2016 Mar 5;387(10022):957-967. doi: 10.1016/S0140-6736(15)01225-8. Epub 2015 Dec 24.
5
Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials.冠状动脉疾病患者的血压目标：来自传统和贝叶斯随机效应荟萃分析随机试验的观察。
Heart. 2013 May;99(9):601-13. doi: 10.1136/heartjnl-2012-301968. Epub 2012 Aug 21.
6
Low DBP may not be an independent risk for cardiovascular death in revascularized coronary artery disease patients.低舒张压可能不是经血管重建的冠心病患者心血管死亡的独立危险因素。
J Hypertens. 2011 Oct;29(10):1889-96. doi: 10.1097/HJH.0b013e32834a5a67.
7
Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis.抗高血压治疗对无高血压人群心血管疾病事件的二级预防作用：一项荟萃分析。
JAMA. 2011 Mar 2;305(9):913-22. doi: 10.1001/jama.2011.250.